Background Among people with a diagnosis of borderline personality disorder (BPD) who
are engaged in clinical care, prescription rates of psychotropic medications are high, despite …

Background Borderline Personality Disorder (BPD) is prevalent (2% in the general
population, 20% among psychiatry in-patients) and has a major impact on health facilities as …

Pharmacological interventions for borderline personality disorder - Stoffers, J - 2010 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Background Over the decades, a variety of psychological interventions for borderline
personality disorder (BPD) have been developed. This review updates and replaces an …

Background Borderline personality disorder (BPD) is a debilitating psychiatric disorder that
affects 0.4–3.9% of the population in Western countries. Currently, no medications have …

Background Psychotherapy is regarded as the first‐line treatment for people with borderline
personality disorder. In recent years, several disorder‐specific interventions have been …

Background Borderline personality disorder (BPD) is a relatively common personality
disorder with a major impact on health services as those affected often present in crisis …

Objective Most patients with borderline personality disorder (BPD) receive
psychopharmacological treatment, but clinical guidelines on BPD lack consensus on the …

Comorbidity between borderline personality disorder (BPD) and other mental disorders is
common. Although no specific pharmacological treatments have been approved for the …

Background Medicines are routinely prescribed to treat borderline personality disorder
(BPD) despite a relative lack of high-quality evidence and in breach of some treatment …